Shares of Cronos Group Inc. (NASDAQ:CRON - Get Free Report) saw an uptick in trading volume on Friday . 2,943,632 shares traded hands during trading, an increase of 122% from the previous session's volume of 1,323,948 shares.The stock last traded at $1.97 and had previously closed at $1.91.
Cronos Group Price Performance
The company has a market capitalization of $753.50 million, a PE ratio of -15.04, a price-to-earnings-growth ratio of 1.74 and a beta of 1.06. The company's fifty day moving average is $1.88 and its 200-day moving average is $1.93.
Cronos Group (NASDAQ:CRON - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.01 by $0.01. The business had revenue of $33.62 million for the quarter, compared to the consensus estimate of $45.44 million. Cronos Group had a negative return on equity of 2.56% and a negative net margin of 42.65%. Equities research analysts forecast that Cronos Group Inc. will post -0.03 EPS for the current fiscal year.
Hedge Funds Weigh In On Cronos Group
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Janney Montgomery Scott LLC boosted its holdings in shares of Cronos Group by 72.2% in the 4th quarter. Janney Montgomery Scott LLC now owns 380,575 shares of the company's stock valued at $769,000 after buying an additional 159,575 shares in the last quarter. Thompson Davis & CO. Inc. purchased a new stake in Cronos Group during the fourth quarter valued at approximately $29,000. Jones Financial Companies Lllp boosted its stake in Cronos Group by 64.5% in the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock valued at $34,000 after acquiring an additional 6,520 shares in the last quarter. SBI Securities Co. Ltd. acquired a new stake in Cronos Group in the fourth quarter valued at approximately $30,000. Finally, Raymond James Financial Inc. purchased a new position in Cronos Group in the fourth quarter worth $641,000. Hedge funds and other institutional investors own 8.71% of the company's stock.
About Cronos Group
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
